FDAnews
www.fdanews.com/articles/159770-roches-avastin-boosts-survival-in-advanced-ovarian-cancer

Roche’s Avastin Boosts Survival in Advanced Ovarian Cancer

October 23, 2013
A new trial conducted in the UK shows that Roche’s Avastin improves long-term survival numbers among women with advanced stages of ovarian cancer.
Pharma Times